Top Markets
#1 Akedo Akedo +59.54%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.99%
#4 Velvet Velvet +41.93%
#5 Black Phoenix Black Phoenix +34.52%
#6 τemplar τemplar +26.67%
#7 Ribbita by Virtuals Ribbita by Virtuals +18.08%
#8 Bitway Bitway +17.19%
#9 Cap Cap +17.11%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.52%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
CohBar, Inc. CohBar, Inc.

CohBar, Inc.

CWBR
Classifica tra le azioni #38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
Prezzo delle azioni
$0.41
Ultima sincronizzazione: 2025-01-23
Capitalizzazione di mercato
$1.08M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia CohBar, Inc. (CWBR)

Categoria

Healthcare
Numero di azioni in circolazione per CohBar, Inc. (CWBR)
Numero di azioni in circolazione al June 2023: 2.91M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di CohBar, Inc., il numero attuale di azioni in circolazione è 2.91M. Alla fine del December 2021, la società aveva 2.22M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di CohBar, Inc. (CWBR) dal 2012 al 2026
Azioni in circolazione alla fine di ogni anno
Anno Azioni in circolazione Cambia
2026 (TTM) 2.91M 0.31%
2022 2.90M 30.54%
2021 2.22M 36.45%
2020 1.63M 14.02%
2019 1.43M 3.78%
2018 1.38M 10.09%
2017 1.25M 13.13%
2016 1.10M 3.37%
2015 1.07M 80.48%
2014 591.75K 37.62%
2013 430.00K 6.70%
2012 403.00K 0.00%
Azioni in circolazione per aziende simili o concorrenti
Azienda Azioni in circolazione Differenza Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 8,634.31%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 2,039.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE